BCRX

BioCryst Pharmaceuticals Inc.

Price

$8.01

return (12m)

12.03%

p/e

-5.30

p/bv

-4.49

DIVIDEND YIELD

0.00%

BCRX price

BioCryst Pharmaceuticals

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment BCRX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-19.46%

3 months

-21.62%

1 year

12.03%

2 years

7.95%

5 years

-39.82%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals BCRX

Valuation

P/E

-5.30

Sector -3.46

Industry -3.46

P/BV

-4.49

Sector 1.94

Industry 1.94

P/Revenue (PSR)

2.17

Sector 1.96

Industry 1.96

EV/EBITDA

20.46

Sector -216.42

Industry -216.42

EV/EBIT

20.57

Sector -46.11

Industry -46.11

P/EBITDA

-6.70

Sector -21.02

Industry -21.02

P/EBIT

-6.66

Sector -27.60

Industry -27.60

P/Total Assets

3.65

Sector 1.14

Industry 1.14

P/Net Current Assets

-3.86

Sector -10.24

Industry -10.24

P/Working Capital

7.39

Sector -162.19

Industry -162.19

EPS

-1.51

Sector -1.78

Industry -1.78

BVPS

-1.79

Sector 1.99

Industry 1.99

Efficiency

Gross Margin

97.78%

Sector 41.35%

Industry 41.35%

EBITDA Margin

46.60%

Sector -17,192.92%

Industry -17,192.92%

EBIT Margin

46.36%

Sector -4,203,320.32%

Industry -4,203,320.32%

Operating Margin

-33.29%

Sector -35.47%

Industry -35.47%

Net Profit Margins

-40.90%

Sector -35.90%

Industry -35.90%

Asset Turnover

0.39

Sector 0.03

Industry 0.03

Profitability

ROE

84.68%

Sector -57.40%

Industry -57.40%

ROA

-68.96%

Sector -59.43%

Industry -59.43%

ROIC

254.66%

Sector -2,370.21%

Industry -2,370.21%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

2.32

Sector 2.91

Industry 2.91

Net Debt / EBITDA

0.42

Sector -21.98

Industry -21.98

Net Debt / EBIT

0.42

Sector -8.44

Industry -8.44

Net Debt / Equity

-0.09

Sector -33,112.99

Industry -33,112.99

Gross Debt / Equity

-0.87

Sector -0.85

Industry -0.85

Equity/Assets

-0.81

Sector 0.46

Industry 0.46

Liabilities/Assets

1.81

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

43.02%

Sector -

Industry -

5Y Earnings CAGR

15.88%

Sector -

Industry -

Fundamentals BCRX

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
BCRX BioCryst Pharmaceuticals Inc.	$8.01	8.68%	0.00%	-5.30	-4.49	84.68%	-40.90%
PFE Pfizer Inc.	$27.48	8.11%	6.26%	36.14	1.83	5.07%	6.80%
ABBV AbbVie Inc.	$259.97	9.77%	2.63%	72.88	-77.57	-106.44%	9.81%
NVO Novo Nordisk A/S	$37.23	-33.47%	4.98%	9.10	4.83	53.11%	35.32%
MRK Merck & Co. Inc.	$143.18	65.09%	2.36%	110.80	8.37	7.56%	4.77%
AZN AstraZeneca PLC	$156.59	-4.79%	2.06%	18.71	4.82	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$60.33	34.59%	4.20%	13.14	5.46	41.59%	18.87%
ZTS Zoetis Inc.	$69.46	-51.82%	3.01%	11.00	9.21	83.77%	27.69%
AMGN Amgen Inc.	$402.15	38.44%	2.47%	24.84	18.58	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$729.88	22.13%	0.51%	17.33	2.37	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$108.98	45.42%	0.00%	30.90	89.03	288.13%	24.86%
MCK McKesson Corporation	$888.29	16.56%	0.38%	22.96	-27.29	-118.84%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$501.27	24.01%	0.00%	28.87	6.28	21.76%	35.00%
CAH Cardinal Health Inc.	$226.17	45.05%	0.91%	30.94	-19.47	-62.92%	0.67%
ARGX argenx SE	$914.13	19.13%	0.00%	20.47	5.36	26.20%	25.70%
HRMY Harmony Biosciences Holdings Inc.	$39.41	46.40%	0.00%	12.60	2.28	18.14%	18.88%
BIIB Biogen Inc.	$220.34	42.87%	0.00%	38.99	1.73	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

BCRX - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT BioCryst Pharmaceuticals

BioCryst Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (3 people)

United States

35 years

Founded: 1991

1994

Time since IPO - 32 years

246

Employees

BioCryst Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $2.04 billion, with shareholders equity totaling $-454.29 million.

The company employs approximately 246 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, BioCryst Pharmaceuticals Inc. reported $940.61 million in revenue, generating net income of $-384.67 million.

Key financial metrics include a P/E ratio of -5.30, a price-to-book (P/B) ratio of -4.49, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker BCRX.

Market cap

$2.04 billion

Net worth

$-454.29 million

$-454,289,000.00

Assets

$557.85 million

$557,851,000.00

Total Shares Outstanding

254.48 million

254,481,000

Average Daily Trading Volume

$4.25 million

$4,246,484.00

Sector

Health Care

Industry

Biotechnology

BCRX

BCRX revenue and profits

Financial Results BCRX

DRAG THE FRAME TO SEE MORE DATA

BCRX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$888.29 20,83% (12M)

P/E

22.96

0.38%

ROE

-118.84%

P/BV

-27.29

CAH - Cardinal Health

$226.17 47,96% (12M)

P/E

30.94

0.91%

ROE

-62.92%

P/BV

-19.47

ABBV - AbbVie

$259.97 14,69% (12M)

P/E

72.88

2.63%

ROE

-106.44%

P/BV

-77.57

MRK - Merck & Co.

$143.18 65,85% (12M)

P/E

110.80

2.36%

ROE

7.56%

P/BV

8.37

AZN - AstraZeneca

$156.59 --6,84% (12M)

P/E

18.71

2.06%

ROE

25.77%

P/BV

4.82

PFE - Pfizer

$27.48 7,47% (12M)

P/E

36.14

6.26%

ROE

5.07%

P/BV

1.83

BMY - Bristol-Myers Squibb

$60.33 39,02% (12M)

P/E

13.14

4.20%

ROE

41.59%

P/BV

5.46

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$888.29 20,83% (12 M)

P/L

22.96

0.38%

ROE

-118.84%

P/VP

-27.29

CAH - Cardinal Health

$226.17 47,96% (12 M)

P/L

30.94

0.91%

ROE

-62.92%

P/VP

-19.47

ABBV - AbbVie

$259.97 14,69% (12 M)

P/L

72.88

2.63%

ROE

-106.44%

P/VP

-77.57

MRK - Merck & Co.

$143.18 65,85% (12 M)

P/L

110.80

2.36%

ROE

7.56%

P/VP

8.37

AZN - AstraZeneca

$156.59 --6,84% (12 M)

P/L

18.71

2.06%

ROE

25.77%

P/VP

4.82

PFE - Pfizer

$27.48 7,47% (12 M)

P/L

36.14

6.26%

ROE

5.07%

P/VP

1.83

BMY - Bristol-Myers Squibb

$60.33 39,02% (12 M)

P/L

13.14

4.20%

ROE

41.59%

P/VP

5.46

Frequently Asked Questions

What is the price of BioCryst Pharmaceuticals (BCRX) today?

The current price of BioCryst Pharmaceuticals (BCRX) is $8.01. The stock began the year trading around $7.80 and is currently priced at $8.01. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does BioCryst Pharmaceuticals (BCRX) pay dividends?

BioCryst Pharmaceuticals (BCRX) did not pay dividends over the past year.

Is BioCryst Pharmaceuticals (BCRX) a good investment?

BioCryst Pharmaceuticals (BCRX) is currently trading at $8.01 with a P/E ratio of -5.30. This represents a -615% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 12.03%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy BioCryst Pharmaceuticals (BCRX) stock?

You can buy BioCryst Pharmaceuticals (BCRX) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol BCRX and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of BioCryst Pharmaceuticals (BCRX) yield today?

Over the past month, BioCryst Pharmaceuticals (BCRX) has returned -19.46% — 12.03% over the past year, and -39.82% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of BioCryst Pharmaceuticals (BCRX) today at the current price of $8.01 your total investment would be $801.00.

Based on historical performance, the investment would have grown to approximately:

$897.36 after 1 year
$482.04 after 5 years
$801.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

BCRX

BioCryst Pharmaceuticals Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment BCRX

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING BCRX WITH OTHER STOCK

ABOUT BioCryst Pharmaceuticals

BioCryst Pharmaceuticals Inc.

United States

35 years

1994

246

PROFIT X PRICE BCRX

Financial Results BCRX

BCRX cash flow

Asset, Revenue and Profit Growth - BCRX

BCRX balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BMY - Bristol-Myers Squibb

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BMY - Bristol-Myers Squibb

Frequently Asked Questions